• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫动脉栓塞术治疗子宫腺肌病所致 Asherman 综合征:发生率预测因素。

Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors.

机构信息

Department of Radiology, The First Affiliated Hospital, Anhui Medical University, 218 Jixi Street, Hefei, 230022, PA, People's Republic of China.

Department of Radiology, Women and Children Health Care Hospital Affiliated Hospital, Anhui Medical University, 15 Yimin Street, Hefei, 230022, PA, People's Republic of China.

出版信息

Radiol Med. 2020 May;125(5):437-443. doi: 10.1007/s11547-020-01136-8. Epub 2020 Feb 4.

DOI:10.1007/s11547-020-01136-8
PMID:32020527
Abstract

PURPOSE

To investigate Asherman syndrome (AS) related to potential factors during uterine artery embolization (UAE) treatment of adenomyosis.

MATERIALS AND METHODS

This is a retrospective analysis of 195 women with adenomyosis who underwent UAE treatment from 2009 to 2016. All preoperative and intraoperative risk-related potential factors of AS were recorded. And AS events were carefully monitored during follow-up (range, 0-15 months). Potential risk-related factors of AS events were determined via univariate and multivariate logistic regression analyses.

RESULTS

The rate of AS events after UAE for adenomyosis was 12.82% (25/195). The univariate and multivariate analyses revealed the association of low vascularity with a significant risk for AS (P = 0.019).

CONCLUSION

Patients with low vascularity of adenomyosis at the time of UAE are more likely to have AS. And adenomyosis patients with low vascularity should be carefully selected to undergo UAE treatment.

摘要

目的

探讨子宫动脉栓塞术(UAE)治疗子宫腺肌病相关的 Asherman 综合征(AS)的潜在因素。

材料与方法

这是一项回顾性分析,纳入了 195 名于 2009 年至 2016 年期间接受 UAE 治疗的子宫腺肌病患者。记录了所有术前和术中与 AS 相关的潜在危险因素。并在随访期间(0-15 个月)仔细监测 AS 事件。通过单因素和多因素 logistic 回归分析确定 AS 事件的潜在风险相关因素。

结果

UAE 治疗子宫腺肌病后 AS 事件的发生率为 12.82%(25/195)。单因素和多因素分析显示,血管低灌注与 AS 的发生显著相关(P=0.019)。

结论

在 UAE 时血管低灌注的子宫腺肌病患者更易发生 AS。因此,血管低灌注的子宫腺肌病患者应谨慎选择接受 UAE 治疗。

相似文献

1
Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors.子宫动脉栓塞术治疗子宫腺肌病所致 Asherman 综合征:发生率预测因素。
Radiol Med. 2020 May;125(5):437-443. doi: 10.1007/s11547-020-01136-8. Epub 2020 Feb 4.
2
Outcomes in Adenomyosis Treated with Uterine Artery Embolization Are Associated with Lesion Vascularity: A Long-Term Follow-Up Study of 252 Cases.子宫动脉栓塞术治疗子宫腺肌病的疗效与病灶血管情况相关:252例长期随访研究
PLoS One. 2016 Nov 2;11(11):e0165610. doi: 10.1371/journal.pone.0165610. eCollection 2016.
3
Uterine Artery Embolization for Adenomyosis.子宫动脉栓塞术治疗子宫腺肌病。
Tech Vasc Interv Radiol. 2021 Mar;24(1):100726. doi: 10.1016/j.tvir.2021.100726. Epub 2021 Apr 20.
4
Long-term follow-up of uterine artery embolization for symptomatic adenomyosis.子宫动脉栓塞术治疗症状性子宫腺肌病的长期随访。
Cardiovasc Intervent Radiol. 2012 Aug;35(4):815-9. doi: 10.1007/s00270-011-0203-1. Epub 2011 Jun 30.
5
Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire.子宫动脉栓塞术治疗症状性子宫腺肌病:使用UFS-Qol问卷进行7年临床随访
Cardiovasc Intervent Radiol. 2017 Sep;40(9):1344-1350. doi: 10.1007/s00270-017-1686-1. Epub 2017 May 17.
6
Low vascularity predicts favourable outcomes in leiomyoma patients treated with uterine artery embolization.低血管化预示着接受子宫动脉栓塞术治疗的平滑肌瘤患者会有良好的预后。
Eur Radiol. 2016 Oct;26(10):3571-9. doi: 10.1007/s00330-016-4223-8. Epub 2016 Jan 27.
7
Inferior Mesenteric Artery Collaterals to the Uterus during Uterine Artery Embolization: Prevalence, Risk Factors, and Clinical Outcomes.子宫动脉栓塞术中对子宫的肠系膜下动脉侧支循环:发生率、危险因素和临床结局。
J Vasc Interv Radiol. 2013 Sep;24(9):1353-60. doi: 10.1016/j.jvir.2013.05.049. Epub 2013 Jul 23.
8
Uterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence.子宫动脉栓塞术治疗子宫腺肌病:坏死百分比可预测中期临床复发情况。
J Vasc Interv Radiol. 2015 Sep;26(9):1290-6.e2. doi: 10.1016/j.jvir.2015.04.026.
9
The evaluation of uterine artery embolization as a nonsurgical treatment option for adenomyosis.子宫动脉栓塞术作为子宫腺肌病非手术治疗选择的评估。
Int J Gynaecol Obstet. 2016 May;133(2):202-5. doi: 10.1016/j.ijgo.2015.09.016. Epub 2015 Dec 31.
10
Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases.子宫肌瘤和子宫腺肌病的子宫动脉栓塞术:基于我们 1300 例经验的图示论文。
Korean J Radiol. 2019 Oct;20(10):1462-1473. doi: 10.3348/kjr.2019.0205.

引用本文的文献

1
A comparison of the treatment outcome of Asherman's syndrome which developed within and outside the puerperal period: A matched cohort study.产褥期内及产褥期外发生的Asherman综合征治疗效果比较:一项配对队列研究。
Acta Obstet Gynecol Scand. 2025 Apr;104(4):774-780. doi: 10.1111/aogs.15057. Epub 2025 Feb 19.
2
A Qualitative Exploration of Emotional Experiences in Patients with Thin Endometrium Undergoing Repeated Cancellations of Frozen-Thawed Embryo Transfer Cycles.对反复取消冻融胚胎移植周期的薄子宫内膜患者情感体验的质性探索
Int J Womens Health. 2025 Jan 22;17:127-137. doi: 10.2147/IJWH.S500794. eCollection 2025.
3
New advances in the treatment of thin endometrium.
薄型子宫内膜治疗的新进展。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1269382. doi: 10.3389/fendo.2024.1269382. eCollection 2024.
4
Comparison of clinical safety and efficacy of ultrasound-guided local lauromacrogol injection versus uterine artery embolization in the treatment of caesarean scar pregnancy: a systematic review and meta-analysis.超声引导下局部注射聚桂醇与子宫动脉栓塞治疗剖宫产瘢痕妊娠的临床安全性和疗效比较:系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2023 Mar 7;23(1):149. doi: 10.1186/s12884-023-05455-2.
5
Precision Imaging Guidance in the Era of Precision Oncology: An Update of Imaging Tools for Interventional Procedures.精准肿瘤学时代的精准成像引导:介入手术成像工具的最新进展
J Clin Med. 2022 Jul 12;11(14):4028. doi: 10.3390/jcm11144028.